YD23
YD23 is a PROTAC that induces SMARCA2 degradation, has anticancer activity, and selectively inhibits the growth of SMARCA4 mutant lung cancer cells in vitro.
Product Specifications
CAS Number
2951015-29-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
738.76
Molecular Formula
C38H39FN8O7
Notes
Research use only, not for human use.
Receptor
PROTACs | Epigenetic Reader Domain
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
sc-492154 5 mg
10-Ethoxy-2-methyl-3- (4-methylphenyl) -2,3,5,6-tetrahydro-4H-2,6-methano-1,3,5-benzoxadiazocine-4-thione
Ask
View Details